Why is continuous dosing with ibrutinib important?

Speakers

John Gribben

Categories / tags

^© Janssen-Cilag Oy 2022. This site is published by Janssen-Cilag Oy which is solely responsible for its content. It is intended for Healthcare professionals in Finland. Janssen-Cilag Oy, PL 15, 02621 Espoo.

Cookie Settings